Dr. Michael Lock, MD
Claim this profileLondon Health Sciences Centre, London Regional Cancer Program
Studies Liver Cancer
Studies Prostate Cancer
3 reported clinical trials
7 drugs studied
Affiliated Hospitals
Clinical Trials Michael Lock, MD is currently running
TACE + SBRT
for Liver Cancer
Trans-arterial chemoembolization (TACE) is a standard treatment for patients with hepatocellular carcinoma (also called liver cancer). This is where chemotherapy is injected into the arteries of the liver and liver cancer. Unfortunately, the tumour grows after TACE in many patients. A new treatment using a specialized radiation procedure called Stereotactic ablative body radiotherapy (SBRT) may increase the chance to control liver cancer. SBRT allows radiation treatments to be focused more precisely, and be delivered more accurately than with older treatments. The purpose of this study is to find out if TACE alone versus TACE plus SBRT is better for you and your liver cancer.
Recruiting2 awards Phase 317 criteria
Standard vs Targeted Radiation Therapy
for Liver Cancer
Radiation is a standard treatment option for patients with liver cancer. Unfortunately, the tumour grows after radiation in many patients and radiation can harm normal tissues. A new treatment using a specialized radiation procedure called Stereotactic body radiotherapy (SBRT) may increase the chance to control liver cancer and reduce the chance of harm to normal tissues. SBRT allows radiation treatments to be focused more precisely, and be delivered more accurately than with older treatments. SBRT has become a routine treatment. Further research has found that specialized computer programs can possibly guide the selection of an appropriate SBRT dose. This is called radiobiological guidance. However, this has not yet been proven to improve outcomes and/or reduce toxicity. Therefore, the purpose of this study is to find out if SBRT at standard dose versus SBRT guided by radiobiological techniques is better for you and your liver cancer.
Recruiting1 award N/A18 criteria
More about Michael Lock, MD
Clinical Trial Related6 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Michael Lock, MD has experience with
- Stereotactic Body Radiation Therapy
- Transarterial Chemoembolization
- Enzalutamide
- Goserelin Acetate
- Leuprolide Acetate
- Triptorelin
Breakdown of trials Michael Lock, MD has run
Prostate Cancer
Liver Metastases
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael Lock, MD specialize in?
Michael Lock, MD focuses on Liver Cancer and Prostate Cancer. In particular, much of their work with Liver Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Michael Lock, MD currently recruiting for clinical trials?
Yes, Michael Lock, MD is currently recruiting for 2 clinical trials in London Ontario. If you're interested in participating, you should apply.
Are there any treatments that Michael Lock, MD has studied deeply?
Yes, Michael Lock, MD has studied treatments such as Stereotactic Body Radiation Therapy, Transarterial Chemoembolization, Enzalutamide.
What is the best way to schedule an appointment with Michael Lock, MD?
Apply for one of the trials that Michael Lock, MD is conducting.
What is the office address of Michael Lock, MD?
The office of Michael Lock, MD is located at: London Health Sciences Centre, London Regional Cancer Program, London, Ontario N6A 5W9 Canada. This is the address for their practice at the London Health Sciences Centre, London Regional Cancer Program.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.